Federal Register / Vol. 87, No. 10 / Friday, January 14, 2022 / Notices 2437 

consultancies, non-financial scientific 

interests, and research grants or 

contracts. 

To obtain a diversity of perspectives, 

AHRQ particularly encourages 

nominations of women, members of 

underrepresented populations, and 

persons with disabilities. Interested 

individuals can nominate themselves. 

Organizations and individuals may 

nominate one or more people qualified 

for membership on the USPSTF at any 

time. Individuals nominated prior to 

March 15, 2021, who continue to have 

interest in serving on the USPSTF 

should be re-nominated. 

Qualification Requirements 

To qualify for the USPSTF and 

support its mission, an applicant or 

nominee should, at a minimum, 

demonstrate knowledge, expertise, and 

national leadership in the following 

areas: 

1. The critical evaluation of research 

published in peer-reviewed literature 

and in the methods of evidence review; 

2. Clinical prevention, health 

promotion and primary health care; and 

3. Implementation of evidence-based 

recommendations in clinical practice 

including at the clinician-patient level, 

practice level, and health-system level. 

Additionally, the Task Force benefits 

from members with expertise in the 

following areas: 

D Public Health 

D Health Equity and The Reduction of 

Health Disparities 

D Application of Science to Health 

Policy 

D Decision modeling 

D Dissemination and Implementation 

D Behavioral Medicine/Clinical Health 

Psychology 

D Communication of Scientific Findings 

to Multiple Audiences Including 

Health Care Professionals, Policy 

Makers, and the General Public 

Candidates with experience and skills 

in any of these areas should highlight 

them in their nomination materials. 

Applicants must have no substantial 

conflicts of interest, whether financial, 

professional, or intellectual, that would 

impair the scientific integrity of the 

work of the USPSTF and must be 

willing to complete regular conflict of 

interest disclosures. 

Applicants must have the ability to 

work collaboratively with a team of 

diverse professionals who support the 

mission of the USPSTF. Applicants 

must have adequate time to contribute 

substantively to the work products of 

the USPSTF. 

Nominee Selection 

Nominated individuals will be 

selected for the USPSTF on the basis of 

how well they meet the required 

qualifications and the current expertise 

needs of the USPSTF. It is anticipated 

that new members will be invited to 

serve on the USPSTF beginning in 

January, 2023. All nominated 

individuals will be considered; 

however, strongest consideration will be 

given to individuals with demonstrated 

training and expertise in the areas of 

Internal Medicine, Pediatrics, and 

Advanced Practice Nursing. AHRQ will 

retain and may consider for future 

vacancies nominations received this 

year and not selected during this cycle. 

Some USPSTF members without 

primary health care clinical experience 

may be selected based on their expertise 

in methodological issues such as metaanalysis, analytic modeling, or clinical 

epidemiology. For individuals with 

clinical expertise in primary health care, 

additional qualifications in 

methodology would enhance their 

candidacy. 

Background 

Under Title IX of the Public Health 

Service Act, AHRQ is charged with 

enhancing the quality, appropriateness, 

and effectiveness of health care services 

and access to such services. 42 U.S.C. 

299(b). AHRQ accomplishes these goals 

through scientific research and 

promotion of improvements in clinical 

practice, including clinical prevention 

of diseases and other health conditions. 

See 42 U.S.C. 299(b). 

The USPSTF, an independent body of 

experts in prevention and evidencebased medicine, works to improve the 

health of all Americans by making 

evidence-based recommendations about 

the effectiveness of clinical preventive 

services and health promotion. The 

recommendations made by the USPSTF 

address clinical preventive services for 

adults and children, and include 

screening tests, counseling services, and 

preventive medications. 

The USPSTF was first established in 

1984 under the auspices of the U.S. 

Public Health Service. Currently, the 

USPSTF is convened by the Director of 

AHRQ, and AHRQ provides ongoing 

scientific, administrative, and 

dissemination support for the USPSTF’s 

operation. See 42 U.S.C. 299b–4(a)(1). 

USPSTF members are invited to serve 

four year terms. New members are 

selected each year to replace those 

members who are completing their 

appointments. 

The USPSTF rigorously evaluates the 

effectiveness of clinical preventive 

services and formulating or updating 

recommendations regarding the 

appropriate provision of preventive 

services. Current USPSTF 

recommendations and associated 

evidence reviews are available on the 

internet (www.uspreventiveservices

taskforce.org). 

USPSTF members meet three times a 

year for two days in the Washington, DC 

area or virtually if necessary. A 

significant portion of the USPSTF’s 

work occurs between meetings during 

conference calls and via email 

discussions. Member duties include 

prioritizing topics, designing research 

plans, reviewing and commenting on 

systematic evidence reviews, discussing 

evidence and making recommendations 

on preventive services, reviewing 

stakeholder comments, drafting final 

recommendation documents, and 

participating in workgroups on specific 

topics and methods. Members can 

expect to receive frequent emails, can 

expect to participate in multiple 

conference calls each month, and can 

expect to have periodic interaction with 

stakeholders. AHRQ estimates that 

members devote approximately 200 

hours a year outside of in-person 

meetings to their USPSTF duties. The 

members are all volunteers and do not 

receive any compensation beyond 

support for travel to attend the thrice 

yearly meetings and trainings. 

Dated: January 7, 2022. 

Marquita Cullom, 

Associate Director. 

[FR Doc. 2022–00488 Filed 1–13–22; 8:45 am] 

BILLING CODE 4160–90–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended, and the Determination of 

the Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, CDC, pursuant to 

Public Law 92–463. The grant 

applications and the discussions could 

disclose confidential trade secrets or 

commercial property such as patentable 

material, and personal information 

concerning individuals associated with 


lotter on DSK11XQN23PROD with NOTICES1
2438 Federal Register / Vol. 87, No. 10 / Friday, January 14, 2022 / Notices 

the grant applications, the disclosure of 

which would constitute a clearly 

unwarranted invasion of personal 

privacy. 

Name of Committee: Disease, 

Disability, and Injury Prevention and 

Control Special Emphasis Panel; 

(SEP)—RFA–CK–22–005, Vector-Borne 

Disease Regional Centers of Excellence. 

Dates: March 17–18, 2022. 

Times: 10:00 a.m.–5:00 p.m., EDT. 

Place: Teleconference, Centers for 

Disease Control and Prevention, Room 

1080, 8 Corporate Square Boulevard, 

Atlanta, GA 30329–4027. 

Agenda: To review and evaluate grant 

applications. 

For Further Information Contact: 

Gregory Anderson, M.S., M.P.H., 

Scientific Review Officer, National 

Center for HIV, Viral Hepatitis, STD, 

and TB Prevention, CDC, 1600 Clifton 

Road NE, Mailstop US8–1, Atlanta, 

Georgia 30329–4027, Telephone: (404) 

718–8833, Email: GAnderson@cdc.gov. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2022–00717 Filed 1–13–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended, and the Determination of 

the Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, CDC, pursuant to 

Public Law 92–463. The grant 

applications and the discussions could 

disclose confidential trade secrets or 

commercial property such as patentable 

material, and personal information 

concerning individuals associated with 

the grant applications, the disclosure of 

which would constitute a clearly 

unwarranted invasion of personal 

privacy. 

Name of Committee: Disease, 

Disability, and Injury Prevention and 

Control Special Emphasis Panel (SEP)— 

RFA–CE–22–008, Using Data Linkage to 

Improve Our Understanding of Suicide/ 

Self-inflicted Injury and/or Drowning. 

Date: May 24–25, 2022. 

Time: 8:30 a.m.–5:30 p.m., EDT. 

Place: Videoconference. 

Agenda: To review and evaluate grant 

applications. 

For Further Information Contact: 

Mikel Walters, Ph.D., Scientific Review 

Officer, National Center for Injury 

Prevention and Control, CDC, 4770 

Buford Highway NE, Mailstop S106–9, 

Atlanta, Georgia 30341–3717, 

Telephone: (404) 639–0913, Email: 

MWalters@cdc.gov. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2022–00722 Filed 1–13–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended, and the Determination of 

the Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, CDC, pursuant to 

Public Law 92–463. The grant 

applications and the discussions could 

disclose confidential trade secrets or 

commercial property such as patentable 

material, and personal information 

concerning individuals associated with 

the grant applications, the disclosure of 

which would constitute a clearly 

unwarranted invasion of personal 

privacy. 

Name of Committee: Disease, 

Disability, and Injury Prevention and 

Control Special Emphasis Panel (SEP)— 

RFA–CE–22–007: Reduce Health 

Disparities and Improve Traumatic 

Brain Injury (TBI) Related Outcomes 

Through the Implementation of CDC’s 

Pediatric Mild TBI Guideline. 

Date: June 6–7, 2022. 

Time: 8:30 a.m.–5:30 p.m., EDT. 

Place: Videoconference. 

Agenda: To review and evaluate grant 

applications. 

For Further Information Contact: 

Mikel Walters, Ph.D., Scientific Review 

Official, National Center for Injury 

Prevention and Control, CDC, 4770 

Buford Highway NE, Mailstop F–63, 

Atlanta, Georgia 30341, Telephone (404) 

639–0913, MWalters@cdc.gov. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2022–00719 Filed 1–13–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended, and the Determination of 

the Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, CDC, pursuant to 

Public Law 92–463. The grant 

applications and the discussions could 

disclose confidential trade secrets or 

commercial property such as patentable 

material, and personal information 

concerning individuals associated with 


lotter on DSK11XQN23PROD with NOTICES1